Almac Clinical Services has launched their web based clinical Label Approval System – LAS a workflow-based label approval management system. LAS gives users full online review, amendment, traceability and control functionality.This is the latest addition to the Almac Clinical Services portfolio.
Key Features
The Label Approval System (LAS) has a number of key features that will enhance the overall label approval process allowing the seamless coordination of approvals among multiple approvers.
· Label proofs are automatically sent to predefined user groups
· Users have instant visibility to the status of all label approval tasks
· Automatic email notifications are sent to designated approvers when labels are available
· Identify bottlenecks in the clinical trial label approval process for future improvements.
· Online pdf mark-up brava reader tool to clearly specify changes to label design
· Automatic notification of ‘late’ tasks
· Generate multiple reports
- Current Status Reports – “What labels are with Almac & affiliates and for how long?”
- History Reports – “Who did what in a specific time period”
- Label Lifecycle Reports – “How long did the design, approval, changes take per label?”
Paul O’Connor, Vice President of Quality, Almac Clinical Services commenting on the launch of the new system said ‘ I am delighted to announce the launch of our new Label Approval System – we have invested significantly in the development of this new system which is the latest in a series of process improvements to remove bottlenecks in the clinical supply chain.’
This latest launch also coincides with the launch of a new web based Shipping Temperature Electronic Monitoring System – stems.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.